• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Deloitte Radical Interoperability Survey Results


Pharmaceutical Executive

Deloitte-audit, consulting, tax, and advisory services company-announced the results of its Radical Interoperability survey, conducted by the Deloitte Center for Health Solutions.

The report provides insights for healthcare stakeholders that want to emerge as a leader in their use of data and analytics in the future of health. This includes the need to prioritize interoperability at the leadership level; developing a bold investment strategy that focuses on strategic, future-looking opportunities; and leveraging the coming compliance, privacy, and security regulations as a key catalyst to drive enterprise momentum.

The report identifies that while regulations are one of the biggest drivers (47%) for broader interoperability, value-based care is the greatest driver (51%) in this pursuit. Furthermore, a recognition of consumer demand for transparency and access-particularly among younger generations-is one of the top drivers (41%).

Recent Videos
Related Content